Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anthrax Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2940105
    • |
  • 14 February, 2019
    • |
  • Global
    • |
  • 139 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Scope of the Report:
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.

Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.

South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.

South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.

Along with the development of China 's Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is the major manufacturer of Anthrax Vaccines used for animal, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Anthrax Vaccines is expected to grow at a CAGR of roughly 7.5% over the next five years, will reach 720 million US$ in 2024, from 500 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anthrax Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Emergent BioSolutions
Merial
Merck
Zoetis 
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Live Vaccines
Cell free PA Vaccines

Market Segment by Applications, can be divided into
Human Use
Animal Use

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anthrax Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anthrax Vaccines, with price, sales, revenue and global market share of Anthrax Vaccines in 2017 and 2018.
Chapter 3, the Anthrax Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anthrax Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anthrax Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anthrax Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Anthrax Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Live Vaccines
      • 1.2.2 Cell free PA Vaccines
    • 1.3 Market Analysis by Applications
      • 1.3.1 Human Use
      • 1.3.2 Animal Use
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Emergent BioSolutions
      • 2.1.1 Business Overview
      • 2.1.2 Anthrax Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Merial
      • 2.2.1 Business Overview
      • 2.2.2 Anthrax Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Merck
      • 2.3.1 Business Overview
      • 2.3.2 Anthrax Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Zoetis
      • 2.4.1 Business Overview
      • 2.4.2 Anthrax Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bayer Sanidad Animal
      • 2.5.1 Business Overview
      • 2.5.2 Anthrax Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Colorado Serum
      • 2.6.1 Business Overview
      • 2.6.2 Anthrax Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 PharmAthene
      • 2.7.1 Business Overview
      • 2.7.2 Anthrax Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Tiankang
      • 2.8.1 Business Overview
      • 2.8.2 Anthrax Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Biogénesis-Bago
      • 2.9.1 Business Overview
      • 2.9.2 Anthrax Vaccines Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 CAVAC
      • 2.10.1 Business Overview
      • 2.10.2 Anthrax Vaccines Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Rosenbusch
      • 2.11.1 Business Overview
      • 2.11.2 Anthrax Vaccines Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Agrovet
      • 2.12.1 Business Overview
      • 2.12.2 Anthrax Vaccines Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Vecol
      • 2.13.1 Business Overview
      • 2.13.2 Anthrax Vaccines Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 CVCRI
      • 2.14.1 Business Overview
      • 2.14.2 Anthrax Vaccines Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 IVPM
      • 2.15.1 Business Overview
      • 2.15.2 Anthrax Vaccines Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Prondil
      • 2.16.1 Business Overview
      • 2.16.2 Anthrax Vaccines Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 CDV
      • 2.17.1 Business Overview
      • 2.17.2 Anthrax Vaccines Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Indian Immunologicals
      • 2.18.1 Business Overview
      • 2.18.2 Anthrax Vaccines Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Botswana Vaccine Institute
      • 2.19.1 Business Overview
      • 2.19.2 Anthrax Vaccines Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Ceva Santé Animale
      • 2.20.1 Business Overview
      • 2.20.2 Anthrax Vaccines Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Intervac
      • 2.21.1 Business Overview
      • 2.2.2 Anthrax Vaccines Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 JOVAC
      • 2.22.1 Business Overview
      • 2.22.2 Anthrax Vaccines Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Anthrax Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Anthrax Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Anthrax Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Anthrax Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Anthrax Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Anthrax Vaccines Market Analysis by Regions

    • 4.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Anthrax Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Anthrax Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)

    5 North America Anthrax Vaccines by Country

    • 5.1 North America Anthrax Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America Anthrax Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Anthrax Vaccines Sales and Growth Rate (2014-2019)

    6 Europe Anthrax Vaccines by Country

    • 6.1 Europe Anthrax Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Anthrax Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy Anthrax Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Anthrax Vaccines by Country

    • 7.1 Asia-Pacific Anthrax Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Anthrax Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Anthrax Vaccines Sales and Growth Rate (2014-2019)

    8 South America Anthrax Vaccines by Country

    • 8.1 South America Anthrax Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America Anthrax Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Anthrax Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Anthrax Vaccines by Countries

    • 9.1 Middle East and Africa Anthrax Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Anthrax Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Anthrax Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Anthrax Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Anthrax Vaccines Sales and Growth Rate (2014-2019)

    10 Global Anthrax Vaccines Market Segment by Type

    • 10.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Anthrax Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Anthrax Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Live Vaccines Sales Growth and Price
      • 10.2.1 Global Live Vaccines Sales Growth (2014-2019)
      • 10.2.2 Global Live Vaccines Price (2014-2019)
    • 10.3 Cell free PA Vaccines Sales Growth and Price
      • 10.3.1 Global Cell free PA Vaccines Sales Growth (2014-2019)
      • 10.3.2 Global Cell free PA Vaccines Price (2014-2019)

    11 Global Anthrax Vaccines Market Segment by Application

    • 11.1 Global Anthrax Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Human Use Sales Growth (2014-2019)
    • 11.3 Animal Use Sales Growth (2014-2019)

    12 Anthrax Vaccines Market Forecast (2019-2024)

    • 12.1 Global Anthrax Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Anthrax Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Anthrax Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe Anthrax Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Anthrax Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America Anthrax Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Anthrax Vaccines Market Forecast (2019-2024)
    • 12.3 Anthrax Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global Anthrax Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Anthrax Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 Anthrax Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global Anthrax Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Anthrax Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Anthrax Vaccines . Industry analysis & Market Report on Anthrax Vaccines is a syndicated market report, published as Global Anthrax Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Anthrax Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,780.52
      		4,170.78
      		5,561.04
      		3,246.84
      		4,870.26
      		6,493.68
      		541,314.00
      		811,971.00
      		1,082,628.00
      		289,988.40
      		434,982.60
      		579,976.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo